Viplus Pharmaceuticals Private Limited - Charges

Every charge - open or closed - that lenders have registered against Viplus Pharmaceuticals Private Limited, with the most recent activity a…

2020-11-03 Kukatpally, Telangana Active Unlisted
Share
Connect MCP
VP Viplus Pharmaceuticals Private Limited
Open charges
3
30.86 cr
Closed charges
1
15.00 cr
Total
4
45.86 cr
Open vs closed
Top charge holders (by amount)
Top lenders
#LenderChargesAmount
1 Axis Bank Limited 1 29.95 cr
2 Others 3 15.91 cr
All charges (4) - latest first
Charge ID Charge holder Created Modified Satisfied Amount Status
101226632 Others 31 Jan 2026 - - 25.50 Lakh Open
100769128 Axis Bank Limited 04 Aug 2023 20 Feb 2025 - 29.95 cr Open
100748006 Others 29 Jun 2023 - - 65.00 Lakh Open
100537810 Others 31 Jan 2022 23 Sep 2022 16 Oct 2023 15.00 cr Closed
Frequently Asked Questions - Charges & borrowings
What do "charges" mean for Viplus Pharmaceuticals Private Limited?
Charges are registrable security interests-typically loans or credit facilities-filed with MCA against Viplus Pharmaceuticals Private Limited (CIN: U24299TG2020PTC145526). They indicate assets or undertakings pledged to lenders or charge holders.
What is the difference between open and closed charges?
Open charges are active or not yet fully discharged; closed (or satisfied) charges are recorded as settled or released. Counts and amounts on this page follow the statuses shown in the charge list.
How should I read the open vs closed amounts?
Open and closed amounts summarise registrable amounts by status for quick comparison; individual rows may show charge-specific amounts, holders, and dates for verification.
Who are the "top lenders" or charge holders?
Top lenders group charge holders by bank or institution name and approximate exposure so you can see which lenders appear most prominently for Viplus Pharmaceuticals Private Limited.
Where can I cross-check financial or ownership context?
Pair this Charges view with the Financial and Ownership sections on this company's V1 profile for loans in financial statements and cap table context alongside MCA charge filings.